We are a Contract Development and Manufacturing Organization (CDMO) and technology provider with extensive expertise in cell line engineering, process development, and GMP manufacturing of biopharmaceuticals. Our proprietary technologies accelerate and advance the development of drug candidates – from their inception to industrial market-readiness.
Whether you want to produce an antibody, a therapeutic enzyme, or a virus, ProBioGen is your trusted and highly experienced partner for development and manufacturing. Starting with unique cell lines and all the way to scalable production, our process is tailored to your individual requirements. Expect best-in-class efficiency and competitive timelines combined with excellent customer service. We commit to top results and transparency at every stage.
GMP Production
Cell Lines
Virus Production
Development
Biosimilars
& Biobetters
Enhancing the performance of antibodies by stripping them of fucose, linking antibodies to their drug loads at multiple targeted sites, testing the recombinant protein’s immunogenicity and function in-vitro, increasing productivity to unprecedented levels, or even boosting your viral vector or vaccine – our innovative technologies make those wishes your reality.
Genetic Glyco-Engineering/
ADCC (GlymaxX®)
DirectedLuck® Transposase
with Epigenetic Targeting
Productivity
Increase
Viral Vector
Technologies
Virus Production
Cell Lines
Basel, Switzerland
Booth #802
Do not miss our poster #48 "DirectedLuck® Transposase Targeting and Transposon Design push Expression beyond Limits".
Rome, Italy
Do not miss our poster "Lenti.RiGHT® – Epigenetic targeting delivers cutting-edge lentivirus producer cell lines"
Barcelona, Spain
Dr Volker Sandig, CSO at ProBioGen, will hold a 15-minute presentation in the "Technology Showcases" track on Tuesday, October 29th at 13:30 CET
Barcelona, Spain
Booth # 1304
Dr Thomas Rose, Head of Expression Systems at ProBioGen, will hold a 15-minute presentation in the track "Engineering Antibodies & Beyond" on Wednesday, November 6th at 17:15 CET
Do not miss our poster "DirectedLuck® Transposase Targeting and Transposon Design push Expression beyond Limits".
Are you looking to enhance your program or are you just curious about our company, services, and technologies? Connect with our team and we will get back to you shortly.
